{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:43:23Z","timestamp":1773369803549,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,30]]},"DOI":"10.7759\/cureus.72733","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:36:21Z","timestamp":1730334981000},"source":"Crossref","is-referenced-by-count":1,"title":["Secondary Myiasis in an Immunocompetent Patient With Severe Chromoblastomycosis"],"prefix":"10.7759","author":[{"given":"Adalina","family":"Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine E","family":"LeRoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijal S","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sydney","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin S","family":"Vasquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9742832","article-title":"Reviewing the etiologic agents, microbe-host relationship, immune response, diagnosis, and treatment in chromoblastomycosis","volume":"2021","author":"Passero LF","year":"2021","unstructured":"Passero LF, Cavallone IN, Belda W Jr. Reviewing the etiologic agents, microbe-host relationship, immune response, diagnosis, and treatment in chromoblastomycosis. J Immunol Res. 2021, 2021:9742832. 10.1155\/2021\/9742832","journal-title":"J Immunol Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4103\/idoj.idoj_182_21","article-title":"Unusual presentation of chromoblastomycosis with a brief review of its atypical cutaneous presentations","volume":"13","author":"Pallivalappil N","year":"2022","unstructured":"Pallivalappil N, Nair SP. Unusual presentation of chromoblastomycosis with a brief review of its atypical cutaneous presentations. Indian Dermatol Online J. 2022, 13:140-2. 10.4103\/idoj.idoj_182_21","journal-title":"Indian Dermatol Online J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-6976.2007.00077.x","article-title":"Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis","volume":"31","author":"Santos AL","year":"2007","unstructured":"Santos AL, Palmeira VF, Rozental S, et al.. Biology and pathogenesis of Fonsecaea pedrosoi, the major etiologic agent of chromoblastomycosis. FEMS Microbiol Rev. 2007, 31:570-91. 10.1111\/j.1574-6976.2007.00077.x","journal-title":"FEMS Microbiol Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.112220","article-title":"Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil","volume":"44","author":"Minotto R","year":"2001","unstructured":"Minotto R, Bernardi CD, Mallmann LF, Edelweiss MI, Scroferneker ML. Chromoblastomycosis: a review of 100 cases in the state of Rio Grande do Sul, Brazil. J Am Acad Dermatol. 2001, 44:585-92. 10.1067\/mjd.2001.112220","journal-title":"J Am Acad Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3109\/13693786.2011.571295","article-title":"Invasive squamous cell carcinoma arising from chromoblastomycosis","volume":"50","author":"Jamil A","year":"2012","unstructured":"Jamil A, Lee YY, Thevarajah S. Invasive squamous cell carcinoma arising from chromoblastomycosis. Med Mycol. 2012, 50:99-102. 10.3109\/13693786.2011.571295","journal-title":"Med Mycol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/13693780802538001","article-title":"Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment","volume":"47","author":"Queiroz-Telles F","year":"2009","unstructured":"Queiroz-Telles F, Esterre P, Perez-Blanco M, Vitale RG, Salgado CG, Bonifaz A. Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol. 2009, 47:3-15. 10.1080\/13693780802538001","journal-title":"Med Mycol"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.3109\/13693780903008813","article-title":"Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora","volume":"48","author":"Najafzadeh MJ","year":"2010","unstructured":"Najafzadeh MJ, Rezusta A, Cameo MI, et al.. Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora. Med Mycol. 2010, 48:390-3.","journal-title":"Med Mycol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00032-16","article-title":"Chromoblastomycosis","volume":"30","author":"Queiroz-Telles F","year":"2017","unstructured":"Queiroz-Telles F, de Hoog S, Santos DW, et al.. Chromoblastomycosis. Clin Microbiol Rev. 2017, 30:233-76. 10.1128\/CMR.00032-16","journal-title":"Clin Microbiol Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/260046-secondary-myiasis-in-an-immunocompetent-patient-with-severe-chromoblastomycosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:36:22Z","timestamp":1730334982000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/260046-secondary-myiasis-in-an-immunocompetent-patient-with-severe-chromoblastomycosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,30]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.72733","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,30]]}}}